The B-specific consortium led by Amanda Foks (Leiden Academic Centre for Drug Research, Leiden University, The Netherlands) successfully kicked-off the project B-specific (B-cell related gene and protein markers with prognostic and therapeutic value for CVD). The event was held on the 23rd of October 2023 at the Faculty Club (Academy Building) in Leiden (The Netherlands). Thanks to European Innovation Council (EIC) (Grant Nr. 101115159) for supporting the research to discover new biomarkers and therapeutic targets for atherosclerosis.